Ambu A/S ranks among the weaker positions in its peer group, with a relatively even profile across the main dimensions. The market setup has weakened, with clear trend damage and relative performance under pressure. Price action is lagging the structural profile — current market behavior is not yet confirming the structural position.
Peer-relative scores, weakest to strongest
Ambu A/S develops and sells medical devices, with a focus on endoscopy and patient monitoring. The company operates primarily in the medtech sector.
The market prices Ambu based on continued peer underperformance and margin pressure, not on a sustainable recovery or growth narrative. With an operating margin of 11.0% (Q2 2025/26, down from 14.2% YoY) and a ROIC of just 4.1%—well below the peer median for two years—the company is seen as a turnaround laggard rather than a candidate for rerating. Rather than factoring in potential, the market systematically imposes a discount on Ambu’s valuation in response to every quarter where profitability and convergence with sector standards are not achieved. In the medtech sector, Ambu's discount is especially pronounced because peers like DexCom and HCA deliver stable margins and innovation, while Ambu, despite endoscopy growth, remains weak in anesthesia. Only if Ambu delivers at least two consecutive quarters of margin and capital returns at peer levels will the market's valuation frame shift.
Break down AMBU-B.CO's position across all dimensions with the full interactive tool.
This analysis is rule-based and descriptive. Peer-relative scores are derived from functional peer group comparisons using publicly available financial data. Scores reflect structural positioning only and do not constitute investment advice, a buy or sell recommendation, or a forecast of future performance. AssetNext peer scores are recalculated periodically as new data becomes available.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.